WO2008148573A3 - Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms - Google Patents
Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms Download PDFInfo
- Publication number
- WO2008148573A3 WO2008148573A3 PCT/EP2008/004567 EP2008004567W WO2008148573A3 WO 2008148573 A3 WO2008148573 A3 WO 2008148573A3 EP 2008004567 W EP2008004567 W EP 2008004567W WO 2008148573 A3 WO2008148573 A3 WO 2008148573A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pantothenic acid
- treatment
- active substance
- derivatives
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009148577/15A RU2472499C2 (en) | 2007-06-08 | 2008-06-07 | Therapeutic agent containing combination of active substances containing pantothenic acid or its derivatives for treating allergic symptoms |
BRPI0812750-6A2A BRPI0812750A2 (en) | 2007-06-08 | 2008-06-07 | UNDERSTANDING AN ACTIVE SUBSTANCE COMBINATION FOR TREATMENT OF ALLERGY SYMPTOMS |
EP08773373A EP2164481A2 (en) | 2007-06-08 | 2008-06-07 | Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07011305.5 | 2007-06-08 | ||
EP07011305 | 2007-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008148573A2 WO2008148573A2 (en) | 2008-12-11 |
WO2008148573A3 true WO2008148573A3 (en) | 2009-05-07 |
Family
ID=39926674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/004567 WO2008148573A2 (en) | 2007-06-08 | 2008-06-07 | Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2164481A2 (en) |
BR (1) | BRPI0812750A2 (en) |
RU (1) | RU2472499C2 (en) |
WO (1) | WO2008148573A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010260808A (en) * | 2009-05-01 | 2010-11-18 | Ikeda Mohando:Kk | Oral medicinal composition for improving skin condition |
US9566306B2 (en) * | 2012-04-16 | 2017-02-14 | Zemtsov Enterprises, Llc | Formulations and methods for treatment of wounds and inflammatory skin conditions |
RU2542448C1 (en) * | 2013-10-15 | 2015-02-20 | Открытое акционерное общество "Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко" | Pharmaceutical composition in form of foam aerosol possessing anti-inflammatory, regenerative and antimicrobial action, and method for preparing it |
JP2017529313A (en) * | 2014-08-08 | 2017-10-05 | シンセン ハイタイド バイオファーマシューティカル リミテッド | Liquid pharmaceutical compositions, drug delivery devices, and methods of their preparation and use |
RU2605617C1 (en) * | 2015-06-25 | 2016-12-27 | государственное автономное научное учреждение "Институт стратегических исследований Республики Башкортостан " | Composition for nasal preparation |
ES2653787B1 (en) * | 2016-07-07 | 2018-09-25 | Diater Laboratorio De Diagnóstico Y Aplicaciones Terapéuticas, S.A. | CHROMOGLITIC ACID COMPOSITIONS FOR THE TREATMENT OF DERMATITIS |
RU2646494C1 (en) * | 2017-07-05 | 2018-03-05 | Общество с ограниченной ответственностью "НАТУРА СИБЕРИКА" (сокращенно ООО "НАТУРА СИБЕРИКА") | Cosmetic composition against inflammation on skin for usage as part of the cosmetic products |
WO2020032910A1 (en) * | 2018-08-10 | 2020-02-13 | Наталья Николаевна ТИХОНОВСКАЯ | Pharmaceutical composition, drug and method for treating obstructive bronchopulmonary diseases |
CN111388673A (en) * | 2020-03-22 | 2020-07-10 | 华中科技大学同济医学院附属协和医院 | Anti-allergic external gel film and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2841527A (en) * | 1955-11-07 | 1958-07-01 | Us Vitamin Corp | Medicinal emulsions |
WO2001019330A1 (en) * | 1999-09-15 | 2001-03-22 | Roche Consumer Health Ag | Pharmaceutical and/or cosmetical compositions |
JP2005053907A (en) * | 2003-08-01 | 2005-03-03 | Boehringer Ingelheim Internatl Gmbh | Pharmaceutical composition for treating skin disease containing combination of epinastine and one or more kinds of additional anti-h1-histamines |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
-
2008
- 2008-06-07 WO PCT/EP2008/004567 patent/WO2008148573A2/en active Application Filing
- 2008-06-07 EP EP08773373A patent/EP2164481A2/en not_active Withdrawn
- 2008-06-07 BR BRPI0812750-6A2A patent/BRPI0812750A2/en not_active IP Right Cessation
- 2008-06-07 RU RU2009148577/15A patent/RU2472499C2/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2841527A (en) * | 1955-11-07 | 1958-07-01 | Us Vitamin Corp | Medicinal emulsions |
WO2001019330A1 (en) * | 1999-09-15 | 2001-03-22 | Roche Consumer Health Ag | Pharmaceutical and/or cosmetical compositions |
JP2005053907A (en) * | 2003-08-01 | 2005-03-03 | Boehringer Ingelheim Internatl Gmbh | Pharmaceutical composition for treating skin disease containing combination of epinastine and one or more kinds of additional anti-h1-histamines |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 200521, Derwent World Patents Index; AN 2005-199939, XP002503480 * |
Also Published As
Publication number | Publication date |
---|---|
RU2009148577A (en) | 2011-07-20 |
EP2164481A2 (en) | 2010-03-24 |
BRPI0812750A2 (en) | 2014-12-23 |
RU2472499C2 (en) | 2013-01-20 |
WO2008148573A2 (en) | 2008-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008148573A3 (en) | Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms | |
WO2011061330A3 (en) | Use of physiological cooling active ingredients, and agents containing such active ingredients | |
HK1142062A1 (en) | Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) | |
WO2008128740A8 (en) | Titration of tapentadol | |
MX2011002966A (en) | Pharmaceutical dosage forms comprising poly(e-caprolactone). | |
IN2012DN01435A (en) | ||
IN2012DN02805A (en) | ||
HK1146485A1 (en) | ||
WO2008058547A3 (en) | Alpha-lactalbumin composition | |
WO2007093880A3 (en) | Novel pyrone-indole derivatives and process for their preparation | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
WO2009109654A8 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1 | |
WO2010090494A3 (en) | Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof | |
UA96794C2 (en) | Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon | |
AU2013330679A8 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
EP2746254A3 (en) | Oxadiazole derivative active on sphingosine-1-phosphate (s1p) | |
GB2446341A (en) | Method and system for transdermal drug delivery | |
WO2007098967A3 (en) | Imidazole compounds having pharmaceutical activity towards the sigma receptor | |
WO2008043788A3 (en) | Novel compounds | |
AU2012308243A8 (en) | Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury | |
WO2008092219A3 (en) | Pharmaceutical composition comprising tramadol and ketoprofen | |
IL217519A (en) | Tazarotene derivatives, pharmaceutical compositions comprising them and use thereof for the manufacture of medicaments for the treatment of skin disorders | |
TN2010000266A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
JP2009001575A5 (en) | ||
WO2008063311A3 (en) | Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08773373 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008773373 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009148577 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: PI0812750 Country of ref document: BR Kind code of ref document: A2 Effective date: 20091208 |